Found 5 matching trials
This Trial Evaluates Safety, Pharmacokinetic Profile and Anti-viral Response of BI 207127 and BI 201335 for Patients With Chronic Hepatitis C PHASE2 The objective of this trial is to investigate tolerability, safety, pharmac...
Show More Location
1241.25.002 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 201335 as Softgel Capsule in Naive Hepatitis C Virus (HCV) Patients PHASE2 The current Standard of Care (SOC) for chronic HCV infection, which is pegy...
Show More Location
1220.14.003 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
Japanese Pegylated Interferon (PegIFN) Alfa-2b/Ribavirin (RBV) Combination Trial PHASE3 The aim of this trial is to evaluate the safety and efficacy of BI 201335 g...
Show More Location
1220.54.08104 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
Safety, Tolerance, and Pharmacokinetics of Single Oral Doses of BI 201335 NA and Bioavailability in Healthy Male Subjects PHASE1 The objective of this study was to investigate the safety, tolerability, an...
Show More Location
Multiple Locations
Learn More & Join Trial
Bioavailability of Soft Gelatin Capsule Formulation of BI 201335 NA Compared to the Solution Formulation in Healthy Volunteers PHASE1 The objective of this study was to establish the relative bioavailability o...
Show More Location
Multiple Locations
Learn More & Join Trial